C.D.C. (U.S.)

COVID Data Tracker Weekly Review

2019 Novel Coronavirus (CDC) - Vin, 09/24/2021 - 07:00
A review of the week's key data from CDC's COVID Data Tracker, narrative interpretations, and visualizations.
Categorii: C.D.C. (U.S.)

Notification of Exposure: A Contact Tracer's Guide for COVID-19

2019 Novel Coronavirus (CDC) - Mie, 09/22/2021 - 07:00
A Contact Tracer's Guide for COVID-19 focuses on communication strategies for contact interviews and provides suggested language for each topic area covered in an interview.
Categorii: C.D.C. (U.S.)

Talking with the Patient - A Case Investigator's Guide to COVID-19

2019 Novel Coronavirus (CDC) - Mie, 09/22/2021 - 07:00
This document focuses on communication strategies for case interviews and provides suggested language for case investigators as they cover each topic area during an interview.
Categorii: C.D.C. (U.S.)

Customizable Contact Tracing Notification Letters

2019 Novel Coronavirus (CDC) - Mie, 09/22/2021 - 07:00
Sample letters for K-12 school administrators to respond to COVID-19 cases
Categorii: C.D.C. (U.S.)

Interim Guidelines for COVID-19 Antibody Testing

2019 Novel Coronavirus (CDC) - Mar, 09/21/2021 - 07:00
CDC has developed interim guidance for how healthcare providers, laboratories, and public health staff should use antibody tests for COVID-19. These tests look for the presence of antibodies, which are specific proteins made in response to infections.
Categorii: C.D.C. (U.S.)

Ensuring the Safety of COVID-19 Vaccines in the United States

2019 Novel Coronavirus (CDC) - Mar, 09/21/2021 - 07:00
Safety is a top priority for COVID-19 vaccines. Learn how the U.S. vaccine safety system is ensuring the safety of COVID-19 vaccines.
Categorii: C.D.C. (U.S.)

COVID-19 Vaccines that Require 2 Shots

2019 Novel Coronavirus (CDC) - Lun, 09/20/2021 - 07:00
If you receive a Pfizer-BioNTech or Moderna COVID-19 vaccine, you will need 2 shots to get the most protection.
Categorii: C.D.C. (U.S.)

Health Equity

2019 Novel Coronavirus (CDC) - Lun, 09/20/2021 - 07:00
Systemic health and social inequities have put people from racial and ethnic minority groups at increased risk from COVID-19. Take steps to reduce health disparities.
Categorii: C.D.C. (U.S.)

Healthcare Facilities That Have Implemented COVID-19 Electronic Case Reporting

2019 Novel Coronavirus (CDC) - Vin, 09/17/2021 - 07:00
Healthcare Facilities That Have Implemented COVID-19 Electronic Case Reporting
Categorii: C.D.C. (U.S.)

Strategies for Optimizing Supply of N95 Respirators

2019 Novel Coronavirus (CDC) - Joi, 09/16/2021 - 07:00
Learn how to optimize N95 respirators during COVID-19.
Categorii: C.D.C. (U.S.)

Accessing a COVID-19 Vaccine If You Are Homebound

2019 Novel Coronavirus (CDC) - Mie, 09/15/2021 - 07:00
Steps for accessing a COVID-19 vaccine if you are homebound.
Categorii: C.D.C. (U.S.)

Science Brief: Background Rationale and Evidence for Public Health Recommendations for Fully Vaccinated People

2019 Novel Coronavirus (CDC) - Mie, 09/15/2021 - 07:00
The risks of SARS-CoV-2 infection in fully vaccinated people cannot be completely eliminated, but the benefits of relaxing some measures may outweigh the residual risk. This page offers background rationale and data for public health recommendations for fully vaccinated people.
Categorii: C.D.C. (U.S.)

Workplaces and Businesses

2019 Novel Coronavirus (CDC) - Mar, 09/14/2021 - 07:00
Workplaces and Businesses
Categorii: C.D.C. (U.S.)

Selected Adverse Events Reported after COVID-19 Vaccination

2019 Novel Coronavirus (CDC) - Mar, 09/14/2021 - 07:00
COVID-19 vaccines are safe and effective. Millions of people in the United States have received COVID-19 vaccines, and these vaccines will undergo the most intensive safety monitoring in U.S. history. CDC recommends you get a COVID-19 vaccine as soon as you are eligible. Adverse events described on this page have been reported to the Vaccine Adverse Event Reporting System (VAERS).
Categorii: C.D.C. (U.S.)

Toolkit for Responding to COVID-19 Cases

2019 Novel Coronavirus (CDC) - Mar, 09/14/2021 - 07:00
Toolkit for K-12 school administrators with resources for responding to COVID-19 cases
Categorii: C.D.C. (U.S.)

Duration of Isolation and Precautions for Adults with COVID-19

2019 Novel Coronavirus (CDC) - Mar, 09/14/2021 - 07:00
This guidance outlines key considerations for states and healthcare systems to consider strategies for transferring patients, staff, and supplies between health facilities to optimize patient care, balance resources, and minimize use of crisis care standards. One option is the identification of relief healthcare facilities and establishing or coordinating with existing federal, state, or regional Medical Operation Coordination Cells (MOCC). The implementation of the elements highlighted in this guidance can be found in the Federal MOCC Toolkit reference throughout.
Categorii: C.D.C. (U.S.)

Communication Resources

2019 Novel Coronavirus (CDC) - Mar, 09/14/2021 - 07:00
Provides guidance documents, communications resources, and other communication tools for regarding COVID-19.
Categorii: C.D.C. (U.S.)

Overview of COVID-19 Isolation for K-12 Schools

2019 Novel Coronavirus (CDC) - Lun, 09/13/2021 - 07:00
Information about isolating for COVID-19 in K-12 Schools
Categorii: C.D.C. (U.S.)

Overview of COVID-19 Quarantine for K-12 Schools

2019 Novel Coronavirus (CDC) - Lun, 09/13/2021 - 07:00
Information about COVID-19 quarantine for K-12 schools
Categorii: C.D.C. (U.S.)

Responding to COVID-19 Cases in K-12 Schools: Resources for School Administrators

2019 Novel Coronavirus (CDC) - Lun, 09/13/2021 - 07:00
A guide for school administrators on how to address COVID-19 cases in schools.
Categorii: C.D.C. (U.S.)

Pagini

Subscribe to Asociatia Creierului Iasi agregator - C.D.C. (U.S.)